CBIHCANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

About CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. (CBIH)

CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. (CBIH) is a Drug Manufacturers - Specialty & Generic company headquartered in Houston, TX, United States whose shares trade over-the-counter on the Pink tier.

The company is dedicated to providing services in all therapeutic areas of clinical research through one of our products: Alpha Research Institute, LLC. a Houston-based Research Unit that offers phase I to phase IV Clinical Research Studies. The Company also operates an international learning platform that provides knowledge about cannabinoids' medical benefits: Pharmacology University. We have been researching medical cannabis uses for more than 15 years, as a result, we have published ebooks, audiobooks, videos, and magazines. Cannabis Bioscience International Holdings will unite both experiences, clinical studies, and knowledge about cannabinoids.

Products and services

The company is dedicated to providing services in all therapeutic areas of clinical research through one of our products: Alpha Research Institute, LLC. a Houston-based Research Unit that offers phase I to phase IV Clinical Research Studies. The Company also operates an international learning platform that provides knowledge about cannabinoids' medical benefits: Pharmacology University. We have been researching medical cannabis uses for more than 15 years, as a result, we have published ebooks, audiobooks, videos, and magazines. Cannabis Bioscience International Holdings will unite both experiences, clinical studies, and knowledge about cannabinoids.

CBIH key facts

Ticker symbol

CBIH

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Houston, TX, United States

Country of incorporation

US

Year of incorporation

2003

Employees

15

Estimated market cap

$6.56M (as of Apr 10, 2025)

Shares outstanding

10,931,749,347

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

5/31

CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. leadership

• Dante Picazo — President, CEO
• Jose Angel Torres Torres — Secretary
• Barry J Miller — Counsel
• Charles Tamburello — Head of IR
• John Jones — Treasurer

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with C